ACB chief Meena's powers curtailed by Kejriwal govt

July 1, 2015

New Delhi, Jul 1: AAP government has curtailed the powers of Lt Governor-backed Anti-Corruption Branch chief MK Meena, asking him to only look after training work and monitoring of cases undergoing trial till the High Court decides on the validity of his appointment.kejriwal

The government has asked ACB's Additional Commissioner S S Yadav, backed by Chief Minister Arvind Kejriwal, to supervise the main work including investigation and functioning of the anti-graft body, days after the Delhi High Court refused to restrain Meena from entering office as sought by the Delhi government.

In his order, Vigilance Director Sukesh Kumar Jain also said that Yadav shall report directly to him. According to the Kejriwal government, director of vigilance department of Delhi government is the head of ACB and is competent to allocate work among the officers in the anti-graft body.

"MK Meena has been posted as Joint Commissioner of Police in ACB. Since, there is no regular post of Jt Commissioner of police in ACB and as the matter is sub-judice, Meena will look after the work of training and monitoring of under trail cases till the final outcome of ongoing proceedings in the High Court," Jain said.

"SS Yadav, additional commissioner of police ACB, shall supervise the work of DCPs, ACPs, inspectors and SHO of police station of ACB. He shall also supervise all investigations inquiries and other functions of ACB and its police station.

"So branch officers shall work under his direct control and supervision. He shall report directly to Director (vigilance)," he said in his order.

As per Jain's order, the work allocation in respect of all other officers ACB shall remain unchanged. They shall continue to discharge their duties and report to their supervisor in hierarchy.

Yesterday, government cancelled three orders issued by Meena through which he appointed Inspector Brij Mohan as the new SHO replacing Inspector Vinay Malik.

The government's new move can further intensify the tussle between Lt Governor appointed Meena and AAP government backed Yadav who operates from the same premises.

The face-off between Lt Governor Najeeb Jung and Delhi Chief Minister Arvind Kejriwal had resulted in the Delhi government's ACB having two chiefs.

On June 8, Joint Commissioner Meena, a 1989-batch Indian Police Service officer, took charge of ACB after he was appointed by Jung, superseding Additional Commissioner SS Yadav.

The AAP government had reacted by terming the appointment "illegal" and claimed that there was no post of joint commissioner in ACB.

However on June 29, Delhi High Court asked Meena to act in accordance with the law, while refusing to issue directions to restrain him from entering office as sought by the Delhi government.

Justice V P Vaish also declined Delhi government's pleas to stop Meena from removing the FIR book from ACB headquarter, recording new FIRs and seeking immediate removal of paramilitary personnel posted there.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 2,2020

New Delhi, Aug 2: The Ministry of Health and Family Welfare on Sunday issued fresh guidelines for international passengers coming to India amid the COVID-19 pandemic. The new guidelines will be implemented from 12:01 am on August 8.

The ministry has also asked all passengers to submit a self-declaration form online at least 72 hours before travel.

"All travellers should submit self-declaration form on the on the online portal (www.newdelhiairport.in) at least 72hours before the scheduled travel," the guidelines said.

It also said that those coming to India must give an undertaking that they would undergo mandatory quarantine for 14 days as prescribed by the government. "They should also give an undertaking on the portal that they would undergo mandatory quarantine for 14 days i.e. 7 days paid institutional quarantine at their own cost, followed by 7 days isolation at home with self-monitoring of health," it added.

Giving exemptions in some cases, the guidelines mentioned, "Only for compelling reasons/cases of human distress such as pregnancy, death in the family. Serious illness and parent (s) with children of 10 years or below, home quarantine may be permitted for 14 days."

"If they wish to seek such exemption, they shall apply to the online portal at least 72 hours before boarding. The decision taken by the government as communicated on the online portal will be final," it said further.

The guidelines further said that travellers could request for exemption from institutional quarantine by submitting a negative RT-PCR test report on arrival.

"This test should have been conducted within 96 hours prior to undertaking the journey. The test report should be uploaded on the portal for consideration," it added.

Passengers have also been asked to download the Aarogya Setu app on their mobile phones.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 26,2020

New Delhi, Apr 26: Medical services at Babu Jagjivan Ram Hospital in Jahangirpuri area have been closed and the hospital is being sanitised after 44 staff members including doctors were tested positive for COVID-19, Delhi Health Department said on Saturday.

"Total 44 staff members including doctors at Babu Jagjivan Ram Hospital in Jahangirpuri area of Delhi have tested positive for COVID-19. Test reports of other staff members are awaited. Hospital's medical services have been closed and the hospital is being sanitized," Delhi Health Department said.

Earlier today, Delhi Health Minister Satyendar Jain informed that there are 2,625 coronavirus cases in Delhi, out of which 111 were reported yesterday.

The total number of active cases in the national capital stands at 1,518 while 869 people have recovered so far, the minister further informed. There have been 54 deaths in the national capital, as per the Union Health Ministry.

A total of 26,496 confirmed cases of COVID-19 have been reported in India, including 19,868 active cases, the Ministry of Health and Family Welfare said on Sunday.

824 people have lost their lives due to the infection in the country.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.